PL3289092T3 - Sposób wytwarzania białka terapeutycznego - Google Patents
Sposób wytwarzania białka terapeutycznegoInfo
- Publication number
- PL3289092T3 PL3289092T3 PL16787029T PL16787029T PL3289092T3 PL 3289092 T3 PL3289092 T3 PL 3289092T3 PL 16787029 T PL16787029 T PL 16787029T PL 16787029 T PL16787029 T PL 16787029T PL 3289092 T3 PL3289092 T3 PL 3289092T3
- Authority
- PL
- Poland
- Prior art keywords
- manufacturing
- therapeutic protein
- therapeutic
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/0127—3Beta-hydroxysteroid 3-dehydrogenase (1.1.1.270)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y603/00—Ligases forming carbon-nitrogen bonds (6.3)
- C12Y603/01—Acid-ammonia (or amine)ligases (amide synthases)(6.3.1)
- C12Y603/01002—Glutamate-ammonia ligase (6.3.1.2)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562153178P | 2015-04-27 | 2015-04-27 | |
| EP16787029.4A EP3289092B1 (en) | 2015-04-27 | 2016-04-27 | Method of manufacturing a therapeutic protein |
| PCT/US2016/029472 WO2016176275A1 (en) | 2015-04-27 | 2016-04-27 | Methods of manufacturing therapeutic proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3289092T3 true PL3289092T3 (pl) | 2020-07-13 |
Family
ID=57199650
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16787029T PL3289092T3 (pl) | 2015-04-27 | 2016-04-27 | Sposób wytwarzania białka terapeutycznego |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US10774353B2 (pl) |
| EP (2) | EP3693469A1 (pl) |
| JP (3) | JP2018518985A (pl) |
| CN (2) | CN113981027A (pl) |
| ES (1) | ES2789073T3 (pl) |
| HK (1) | HK1256714A1 (pl) |
| HU (1) | HUE050105T2 (pl) |
| PL (1) | PL3289092T3 (pl) |
| WO (1) | WO2016176275A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016176275A1 (en) | 2015-04-27 | 2016-11-03 | Momenta Pharmaceuticals, Inc. | Methods of manufacturing therapeutic proteins |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101016543A (zh) * | 2000-11-17 | 2007-08-15 | 罗切斯特大学 | 筛选编码抗原特异性免疫球蛋白分子或其抗原特异性片段的多核苷酸的方法 |
| GB0123098D0 (en) * | 2001-09-26 | 2001-11-14 | Lonza Biologics Plc | Use of aminoglycoside resistance gene |
| US8030071B2 (en) * | 2005-03-11 | 2011-10-04 | Gargi Seth | Restoration of cholesterol independence and its use as a selectable marker in NS0 cell culture |
| ES2730216T3 (es) * | 2005-05-18 | 2019-11-08 | Biofactura Inc | Composiciones y métodos para selección metabólica de células transfectadas |
| EP2067038A1 (en) * | 2006-09-15 | 2009-06-10 | Boehringer Ingelheim Pharma GmbH & Co. KG | Methods of selecting cell clones |
| AU2008309934B2 (en) * | 2007-10-12 | 2014-03-06 | F. Hoffmann-La Roche Ag | Protein expression from multiple nucleic acids |
| EP2146210A1 (en) * | 2008-04-07 | 2010-01-20 | Arena Pharmaceuticals, Inc. | Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY |
| ES2699718T3 (es) * | 2009-09-15 | 2019-02-12 | Medlmmune Ltd | Células para expresión transitoria y usos de las mismas |
| US20150150982A1 (en) * | 2012-06-12 | 2015-06-04 | Boehringer Ingelheim International Gmbh | Pharmaceutical formulation for a therapeutic antibody |
| EP2711428A1 (en) * | 2012-09-21 | 2014-03-26 | Lonza Biologics plc. | Site-specific integration |
| WO2016176275A1 (en) | 2015-04-27 | 2016-11-03 | Momenta Pharmaceuticals, Inc. | Methods of manufacturing therapeutic proteins |
-
2016
- 2016-04-27 WO PCT/US2016/029472 patent/WO2016176275A1/en active Application Filing
- 2016-04-27 JP JP2018508614A patent/JP2018518985A/ja active Pending
- 2016-04-27 HU HUE16787029A patent/HUE050105T2/hu unknown
- 2016-04-27 CN CN202111104665.3A patent/CN113981027A/zh active Pending
- 2016-04-27 ES ES16787029T patent/ES2789073T3/es active Active
- 2016-04-27 EP EP19219090.8A patent/EP3693469A1/en active Pending
- 2016-04-27 CN CN201680037233.6A patent/CN108138214B/zh active Active
- 2016-04-27 PL PL16787029T patent/PL3289092T3/pl unknown
- 2016-04-27 US US15/570,178 patent/US10774353B2/en active Active
- 2016-04-27 EP EP16787029.4A patent/EP3289092B1/en active Active
-
2018
- 2018-12-07 HK HK18115711.6A patent/HK1256714A1/zh unknown
-
2020
- 2020-07-01 US US16/918,423 patent/US20210102230A1/en active Pending
-
2021
- 2021-05-21 JP JP2021085859A patent/JP2021137015A/ja active Pending
-
2023
- 2023-06-21 JP JP2023101801A patent/JP2023112080A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US10774353B2 (en) | 2020-09-15 |
| WO2016176275A1 (en) | 2016-11-03 |
| US20180135090A1 (en) | 2018-05-17 |
| EP3289092A4 (en) | 2018-12-12 |
| JP2021137015A (ja) | 2021-09-16 |
| US20210102230A1 (en) | 2021-04-08 |
| ES2789073T3 (es) | 2020-10-23 |
| CN113981027A (zh) | 2022-01-28 |
| EP3693469A1 (en) | 2020-08-12 |
| HK1256714A1 (zh) | 2019-10-04 |
| JP2023112080A (ja) | 2023-08-10 |
| JP2018518985A (ja) | 2018-07-19 |
| EP3289092B1 (en) | 2020-02-12 |
| EP3289092A1 (en) | 2018-03-07 |
| CN108138214A (zh) | 2018-06-08 |
| HUE050105T2 (hu) | 2020-11-30 |
| CN108138214B (zh) | 2021-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL249955B (en) | A method for the computational design of proteins | |
| HK1252568A1 (zh) | 一種治療方法 | |
| EP3398466A4 (en) | MASSAGE SHOE AND METHOD FOR MANUFACTURING THE SAME | |
| GB201716774D0 (en) | Method of manufacturing fluorescent-material-containing member | |
| HK1247818A1 (zh) | 治療疾病的方法 | |
| HK1258994A1 (zh) | 用於疾病治療的方法 | |
| GB201518792D0 (en) | Production of proteins | |
| SG10201912688YA (en) | A method of treatment | |
| IL262544A (en) | A method for producing a recombinant protein | |
| IL252712A0 (en) | Method for protein production | |
| GB2548706B (en) | Method of manufacturing fluorescent-material-containing member | |
| GB201609170D0 (en) | Method of manufacture | |
| HK1250243A1 (zh) | 治療方法 | |
| HK1246679A1 (zh) | 絲蟲病的治療 | |
| HK1243937A1 (zh) | 治療疾病的方法 | |
| SG11201708751RA (en) | Method of producing a recombinant protein | |
| PL3383615T3 (pl) | Sposób formowania części | |
| GB201613971D0 (en) | Method of manufacture | |
| GB201609171D0 (en) | Method of manufacture | |
| HK1256714A1 (zh) | 製備治療性蛋白質的方法 | |
| ZA201607831B (en) | Method of manufacturing a sausage | |
| GB2555309B (en) | A method of manufacturing a sterilized sachet | |
| ZA201801289B (en) | Method of manufacturing hydrocarbons | |
| IL251740B (en) | A method for producing vials of recombinant protein | |
| GB201700099D0 (en) | Therapeutic method |